WallStSmart
IRON

Disc Medicine Inc.

NASDAQ: IRON · HEALTHCARE · BIOTECHNOLOGY

$69.23
-5.78% today

Updated 2026-06-05

Market cap
$2.60B
P/E ratio
P/S ratio
EPS (TTM)
$-6.64
Dividend yield
52W range
$40 – $100
Volume
0.4M

Disc Medicine Inc. (IRON) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item202020212022202320242025
Total assets$8.32M$92.41M$200.21M$368.00M$496.77M$806.88M
Cash & equivalents$4.50M$88.04M$194.61M$360.38M$192.43M$91.14M
Current assets$5.07M$90.48M$198.49M$365.66M$493.62M$803.90M
Total liabilities$30.18M$156.61M$23.61M$22.88M$53.19M$67.05M
Current liabilities$24.88M$13.42M$22.58M$21.44M$23.32M$36.64M
Long-term debt$4.95M$404000.00$28.32M$29.16M
Shareholder equity$-21.86M$-64.20M$176.60M$345.12M$443.59M$739.83M
Retained earnings$-112.82M$-65.39M$-112.22M$-188.65M$-298.00M$-510.19M
Accounts receivable
Inventory
Goodwill

Frequently asked questions

How much free cash flow does IRON generate?

IRON produced $-181.33M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is IRON's balance sheet healthy?

IRON holds $91.14M in cash and equivalents against $29.16M in long-term debt, on $739.83M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.